Kanabo Group (KNB) Competitors GBX 0.36 -0.10 (-21.11%) As of 12:38 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock KNB vs. TLY, SPI, MGP, SBI, SAR, POLB, IMM, IHC, ABDX, and RLMShould you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Sareum (SAR), Poolbeg Pharma (POLB), ImmuPharma (IMM), Inspiration Healthcare Group (IHC), Abingdon Health (ABDX), and Realm Therapeutics (RLM). These companies are all part of the "medical" sector. Kanabo Group vs. Totally Spire Healthcare Group Medica Group Sourcebio International Sareum Poolbeg Pharma ImmuPharma Inspiration Healthcare Group Abingdon Health Realm Therapeutics Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, community ranking, profitability, analyst recommendations and risk. Do insiders & institutionals believe in KNB or TLY? 3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 51.3% of Totally shares are held by institutional investors. 37.0% of Kanabo Group shares are held by company insiders. Comparatively, 13.3% of Totally shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate KNB or TLY? Totally has a consensus price target of GBX 20, suggesting a potential upside of 449.75%. Given Totally's stronger consensus rating and higher possible upside, analysts clearly believe Totally is more favorable than Kanabo Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kanabo Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Totally 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is KNB or TLY more profitable? Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.Company Net Margins Return on Equity Return on Assets Kanabo Group-717.63% -121.77% -20.89% Totally -2.85%-11.01%-2.42% Which has more volatility and risk, KNB or TLY? Kanabo Group has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Does the MarketBeat Community favor KNB or TLY? Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users. CompanyUnderperformOutperformKanabo GroupN/AN/ATotallyOutperform Votes13172.78% Underperform Votes4927.22% Does the media refer more to KNB or TLY? In the previous week, Totally had 3 more articles in the media than Kanabo Group. MarketBeat recorded 3 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 1.42 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the news media. Company Overall Sentiment Kanabo Group Neutral Totally Positive Which has stronger valuation & earnings, KNB or TLY? Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKanabo Group£1.14M1.97-£8.18M-£1.29-0.27Totally£133.05M0.05-£3.79M-£1.93-1.88 SummaryTotally beats Kanabo Group on 12 of the 17 factors compared between the two stocks. Remove Ads Get Kanabo Group News Delivered to You Automatically Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KNB vs. The Competition Export to ExcelMetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON ExchangeMarket Cap£2.25M£1.49B£5.64B£2.60BDividend YieldN/A3.83%4.56%4.95%P/E Ratio-0.276.8423.13141.59Price / Sales1.9717.39383.89290,340.21Price / Cash1.8212.5138.1627.93Price / Book0.381.856.944.62Net Income-£8.18M£58.65M£3.20B£5.78B7 Day Performance-40.83%-1.01%-2.30%0.43%1 Month Performance-50.83%-2.99%3.10%6.15%1 Year Performance-76.33%3.73%11.22%118.05% Kanabo Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KNBKanabo GroupN/AGBX 0.36-21.1%N/A-80.0%£2.25M£1.14M-0.2720Gap DownTLYTotally3.4184 of 5 starsGBX 3.02-3.5%GBX 20+563.3%-31.1%£5.93M£133.05M-1.561,668Insider TradeNews CoverageGap DownSPISpire Healthcare Group2.9508 of 5 starsGBX 180+0.8%GBX 314.67+74.8%-26.4%£722.82M£1.44B25.62420Gap UpMGPMedica GroupN/AN/AN/AN/A£259.85M£76.98M3,516.671,212SBISourcebio InternationalN/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap UpHigh Trading VolumeSARSareumN/AGBX 12.33-1.4%N/A-15.6%£15.40MN/A-2.923,211Earnings ReportInsider TradeNegative NewsGap UpHigh Trading VolumePOLBPoolbeg PharmaN/AGBX 2.89-3.8%N/A-71.7%£14.83MN/A0.0012Gap DownIMMImmuPharmaN/AGBX 3.46+1.8%N/A+28.5%£14.71M£-71,310.29-5.9813IHCInspiration Healthcare GroupN/AGBX 16.37-2.3%N/A-42.8%£14.18M£42.87M-1.12224Gap DownABDXAbingdon HealthN/AGBX 7.22-0.5%N/A-34.1%£13.97M£3.84M-17.5484Earnings ReportNews CoverageRLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501,919.00-0.66N/A Remove Ads Related Companies and Tools Related Companies Totally Alternatives Spire Healthcare Group Alternatives Medica Group Alternatives Sourcebio International Alternatives Sareum Alternatives Poolbeg Pharma Alternatives ImmuPharma Alternatives Inspiration Healthcare Group Alternatives Abingdon Health Alternatives Realm Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:KNB) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kanabo Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kanabo Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
